NCT00193479View on ClinicalTrials.gov

Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

July 31, 2008

Study Completion Date

February 28, 2010

Conditions
Non-Hodgkins Lymphoma
Interventions
DRUG

Cyclophosphamide

Cyclophosphamide

DRUG

Mitoxantrone

Mitoxantrone

DRUG

Vincristine

Vincristine

DRUG

Prednisone

Prednisone

DRUG

Rituximab

Rituximab

Trial Locations (2)

33901

Florida Cancer Specialists, Fort Myers

37203

Tennessee Oncology, Nashville

Sponsors

Collaborators (2)

Genentech, Inc.
Amgen
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

collaborator

Amgen

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER

NCT00193479 - Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter